Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7UY9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,447
Award facts
- Contract value 100% obligated
- $28,446.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,446.68 delivery order to AmerSourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injector pens on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Enbrel is a biologic immunosuppressant used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions, making this delivery order part of DLA's broader effort to supply specialty medications to military treatment facilities and veterans' healthcare programs. AmerSourceBergen, as a major pharmaceutical distributor, regularly fulfills such federal medical procurement needs through competitive awards across multiple therapeutic domains. The short completion timeframe indicates an urgent resupply requirement for this specialty pharmaceutical product within the Defense Health Agency and related military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7UY9?
SPE2DR26F7UY9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F7UY9 worth?
The government has obligated $28,447 on SPE2DR26F7UY9.
Is contract SPE2DR26F7UY9 an order under another contract?
Yes. SPE2DR26F7UY9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UY9 competed?
The extent of competition for SPE2DR26F7UY9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award